[1]
W. Ping, Y. Tao, M. HongYing, L. DanQi, S. Yanghao, and Z. BoTing, “First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy”, J Pharm Pharm Sci, vol. 18, no. 3, pp. 256–285, Jul. 2015.